With ops span­ning Bel­gium and Chi­na, Full-Life inks $245M buy­out to beef up ra­dio­phar­ma pipeline

From the day they in­cor­po­rat­ed Full-Life Tech­nolo­gies just over a year ago, Lan­ny Sun and his co-founders knew they want­ed to in-li­cense and ac­quire promis­ing ra­dio­phar­ma­ceu­ti­cal pro­grams that would fit right in­to the sup­ply chain and lo­gis­tics net­work they’re build­ing.

They’ve now found the tar­get. Full-Life has put to­geth­er a $245 mil­lion deal to buy out Fo­cus-X Ther­a­peu­tics, a tiny start­up work­ing out of New Jer­sey.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER